The medical simulation market is expected to reach USD 2,575.4 Million by 2022 from USD 1.120.8 Million in 2016, at a CAGR of 14.9% during the forecast period (2017–2022).
Medical simulation is the advanced methodology for training healthcare professionals through the use of advanced educational technology. Simulation-based medical education is defined as any educational activity that utilizes simulation aides to replicate clinical scenarios. The benefits of simulation over traditional learning, increasing demand for minimally invasive treatments, and increasing focus on patient safety are the major factors driving the growth of the significant growth drivers of the market. The base year considered for the study is 2016 and the forecast period includes 2017 to 2022.
Geographically, the global medical simulation market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2016, North America accounted for the largest share of the market, followed by Europe and Asia Pacific. The ease of accessibility to technologies, well-established distribution channels, and rising number of healthcare professionals demanding hands on patient training are the major factors driving the growth of the market in North America.
The prominent players in the global Medical Simulation Market are CAE (Canada), Laerdal Medical (Norway), 3D Systems (US), Simulab Corporation (US), Simulaids (US), Limbs & Things (US), Kyoto Kagaku (Japan), Mentice (Sweden), Medaphor (UK), and Gaumard Scientific Company (US).
Know More:
https://www.marketsandmarkets.com/Market-Reports/healthcare-medical-simulation-market-1156.html
